TRANSCODE THERAPEUTICS INC COM NEW 2025
TRANSCODE THERAPEUTICS INC COM NEW 2025 is a security (CUSIP 89357L501) tracked across SEC portfolio filings. 7 institutional managers reported $184K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $55K via N-PORT as of 2026-03-31.
Summary
- Issuer: TRANSCODE THERAPEUTICS INC
- Class: COM NEW 2025
- CUSIP: 89357L501
- Asset category: EC
- 13F holders: 7
- 13F value: $184K
- 13F period: 2026-06-30
- N-PORT fund positions: 2
- N-PORT value: $55K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $110K | 12,740 |
| UBS Group AG | Zurich, V8 | $71K | 8,295 |
| Tower Research Capital LLC (TRC) | NEW YORK, NY | $2K | 228 |
| WELLS FARGO & COMPANY/MN | SAN FRANCISCO, CA | $474 | 55 |
| SBI Securities Co., Ltd. | TOKYO, M0 | $75 | 12 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
| Royal Bank of Canada | TORONTO, A6 | — | 8 |
Top fund holders (N-PORT)
More